Cite
HARVARD Citation
Mody, R. et al. (2022). Are we there yet? Increasing use of cardioprotective antihyperglycemic agents in patients with T2D and CVD or CV risk in the United States. Current medical research and opinion. pp. 1785-1795. [Online].